how to get on retatrutide trial produces up 30.3% weight loss in Phase 3 retatrutide trial results today A

Long-term effects, potential drug interactions, and effects in specific populations including pregnant women, children, and those with certain medical conditions have not been studied

While early research is promising, it is still an experimental compound with limited human data

Watch our webinar, Emerging clinical applications for GLP-1 receptor agonists, to learn more

The article says gastrointestinal symptoms typically emerge within the first week and peak around days 3 to 7 after starting treatment, with most patients seeing resolution within 4 to 8 weeks as the gastrointestinal tract adapts

Level up your skincare, why not to try these lotions